110 related articles for article (PubMed ID: 26179887)
21. Breast erythema and induration in a 77-year-old woman.
Woo DK; Reilly GD; Elenitsas R
Arch Dermatol; 2006 Jan; 142(1):101-6. PubMed ID: 16415396
[No Abstract] [Full Text] [Related]
22. Toxic epidermal necrolysis in patient with breast cancer receiving letrozole.
Chia WK; Lim YL; Greaves MW; Ang P
Lancet Oncol; 2006 Feb; 7(2):184-5. PubMed ID: 16455483
[No Abstract] [Full Text] [Related]
23. [A case of breast cancer with chronic renal failure successfully treated with TC therapy as adjuvant chemotherapy].
Oshiro C; Arai T; Kamigaki S; Matsuura M
Gan To Kagaku Ryoho; 2012 Feb; 39(2):265-7. PubMed ID: 22333640
[TBL] [Abstract][Full Text] [Related]
24. Skin involvement in scleroderma--where histological and clinical scores meet.
Verrecchia F; Laboureau J; Verola O; Roos N; Porcher R; Bruneval P; Ertault M; Tiev K; Michel L; Mauviel A; Farge D
Rheumatology (Oxford); 2007 May; 46(5):833-41. PubMed ID: 17255134
[TBL] [Abstract][Full Text] [Related]
25. Clinical and pathological significance of interleukin 6 overexpression in systemic sclerosis.
Khan K; Xu S; Nihtyanova S; Derrett-Smith E; Abraham D; Denton CP; Ong VH
Ann Rheum Dis; 2012 Jul; 71(7):1235-42. PubMed ID: 22586157
[TBL] [Abstract][Full Text] [Related]
26. Hand-foot syndrome caused by docetaxel with no recurrence after switch to paclitaxel, a different taxane.
Corazza M; Minghetti S; Borghi A; Virgili A; Ballardini P
Int J Dermatol; 2014 Mar; 53(3):e180-2. PubMed ID: 23621794
[No Abstract] [Full Text] [Related]
27. [Clinical significance and pathological evaluation of neoadjuvant chemotherapy in breast cancer].
Chen LR
Zhonghua Bing Li Xue Za Zhi; 2010 Apr; 39(4):218-21. PubMed ID: 20654118
[No Abstract] [Full Text] [Related]
28. High thioredoxin expression is associated with resistance to docetaxel in primary breast cancer.
Kim SJ; Miyoshi Y; Taguchi T; Tamaki Y; Nakamura H; Yodoi J; Kato K; Noguchi S
Clin Cancer Res; 2005 Dec; 11(23):8425-30. PubMed ID: 16322305
[TBL] [Abstract][Full Text] [Related]
29. A case of peplomycin-induced scleroderma.
Asano Y; Ihn H; Shikada J; Kadono T; Kikuchi K; Tamaki K
Br J Dermatol; 2004 Jun; 150(6):1213-4. PubMed ID: 15214916
[No Abstract] [Full Text] [Related]
30. Hypoxia-induced increase in the production of extracellular matrix proteins in systemic sclerosis.
Distler JH; Jüngel A; Pileckyte M; Zwerina J; Michel BA; Gay RE; Kowal-Bielecka O; Matucci-Cerinic M; Schett G; Marti HH; Gay S; Distler O
Arthritis Rheum; 2007 Dec; 56(12):4203-15. PubMed ID: 18050252
[TBL] [Abstract][Full Text] [Related]
31. Relative effectiveness of adjuvant chemotherapy for invasive lobular compared with invasive ductal carcinoma of the breast.
Marmor S; Hui JYC; Huang JL; Kizy S; Beckwith H; Blaes AH; Rueth NM; Tuttle TM
Cancer; 2017 Aug; 123(16):3015-3021. PubMed ID: 28382636
[TBL] [Abstract][Full Text] [Related]
32. Chick embryo back skin organ and fibroblast cultures. Extracellular matrix changes induced by dialysate fluid and uraemic toxins in relation to proliferation and differentiation processes.
Stabellini G; Calastrini C; Pezzetti F; DeMattei M; Dellavia C; Moscheni C; Pellati A; Bedani PL; Vertemati M; Bodo-Lumare M
Pathology; 2003 Jun; 35(3):231-9. PubMed ID: 14506968
[TBL] [Abstract][Full Text] [Related]
33. Randomized, placebo-controlled, double-blind, phase II study of axitinib plus docetaxel versus docetaxel plus placebo in patients with metastatic breast cancer.
Rugo HS; Stopeck AT; Joy AA; Chan S; Verma S; Lluch A; Liau KF; Kim S; Bycott P; Rosbrook B; Bair AH; Soulieres D
J Clin Oncol; 2011 Jun; 29(18):2459-65. PubMed ID: 21555686
[TBL] [Abstract][Full Text] [Related]
34. Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts.
Nakashima T; Jinnin M; Yamane K; Honda N; Kajihara I; Makino T; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
J Immunol; 2012 Apr; 188(8):3573-83. PubMed ID: 22403442
[TBL] [Abstract][Full Text] [Related]
35. Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells.
Soon PS; Kim E; Pon CK; Gill AJ; Moore K; Spillane AJ; Benn DE; Baxter RC
Endocr Relat Cancer; 2013 Feb; 20(1):1-12. PubMed ID: 23111755
[TBL] [Abstract][Full Text] [Related]
36. Breast cancer during pregnancy. Approach to rational management.
Lishner M; Koren G
Can Fam Physician; 1998 Feb; 44():265-6. PubMed ID: 9512826
[TBL] [Abstract][Full Text] [Related]
37. Docetaxel rechallenge after a first response in non-resistant metastatic breast cancer: significant activity with manageable toxicity.
Toulmonde M; Madranges N; Brouste V; Donamaria C; MacGrogan G; Durand M; Bonnefoi H; Mauriac L; Debled M
Breast Cancer Res Treat; 2012 Jul; 134(1):325-32. PubMed ID: 22531859
[TBL] [Abstract][Full Text] [Related]
38. Therapy-related leukemia cutis after adjuvant chemotherapy in a breast cancer patient.
Lee HY; Ng HJ; Wong PC; Pang SM
Acta Derm Venereol; 2010 Nov; 90(6):649-50. PubMed ID: 21057758
[No Abstract] [Full Text] [Related]
39. The antifibrotic role of hepatocyte growth factor in dermal fibroblasts of systemic sclerosis.
Cao HL; Dou TT; Yang JQ; Jing J; Zheng M; Man XY
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S197-8. PubMed ID: 26005880
[No Abstract] [Full Text] [Related]
40. Psoriasis induced by trastuzumab therapy.
de Lorenzi C; Kaya G; Quenan S
Eur J Dermatol; 2018 Oct; 28(5):702-704. PubMed ID: 30378545
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
